FDA Human Foods Program
The following is an update from FDA of concern to our subscribers.
Outbreak Investigation of Salmonella: Moringa Leaf Powder (May 2026)
Do not eat or sell recalled MOGO-brand moringa powder capsules. FDA’s investigation is ongoing.
May 26, 2026
The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis, MO. This is a new outbreak and this investigation is separate from previous outbreaks of Salmonella Newport & Kentucky and Salmonella Typhimurium & Newport that were both linked to moringa powder.
Based on epidemiological information collected by CDC, a total of 18 people infected with the outbreak strain of Salmonella have been reported from 14 states. Illnesses started on dates ranging from February 3, 2026, to April 7, 2026. Of the 7 people interviewed, 5 (71%) reported eating moringa powder capsules, including 4 who reported MOGO-brand moringa powder capsules. There have been 7 hospitalizations, and no deaths have been reported.
On May 25, 2026, MOGO Moringa LLC recalled lot #15525AA EXP 6/2027 and lot #00926AA EXP 1/2028 of MOGO-brand Pure Moringa Oleifera capsules. Consumers and retailers who purchased recalled MOGO-brand moringa powder capsules should not eat, sell, or further distribute this product and should throw it away. Consumers who purchased recalled products are encouraged to visit the company’s official recall information page.
FDA is conducting a traceback investigation to determine a source of contamination and is working with state partners to collect samples. FDA will update this advisory with new information as it becomes available. FDA’s investigation is ongoing.
|
